MAPT and Alzheimer disease: Tau-SUMOylation could induce tau to be hyperphosphorylated at a series of AD-associated sites, and tau hyperphosphorylation can in turn promote its SUMOylation and inhibit tau degradation by reducing tau protein solubility and ubiquitination [106].